Evidence map›Paper›PMID 32459967›Full record

ArticleJournal of natural products2020

Hydroxylated Rotenoids Selectively Inhibit the Proliferation of Prostate Cancer Cells.

David A Russell, Hannah R Bridges, Riccardo Serreli, Sarah L Kidd, Natalia Mateu, Thomas J Osberger, Hannah F Sore, Judy Hirst, David R Spring

Open access · greenAbstract read
In one paragraph

Article in Journal of natural products, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

David A RussellDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, U.K.ORCID 0000-0002-2182-4178
Hannah R BridgesMRC Mitochondrial Biology Unit, University of Cambridge, Keith Peters Building, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0XY, U.K.
Riccardo SerreliMRC Mitochondrial Biology Unit, University of Cambridge, Keith Peters Building, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0XY, U.K.
Sarah L KiddDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, U.K.
Natalia MateuDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, U.K.
Thomas J OsbergerDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, U.K.
Hannah F SoreDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, U.K.
Judy HirstMRC Mitochondrial Biology Unit, University of Cambridge, Keith Peters Building, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0XY, U.K.ORCID 0000-0001-8667-6797
David R SpringDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, U.K.ORCID 0000-0001-7355-2824
University of Cambridge · GBMRC Mitochondrial Biology Unit · GB

Funding

Cancer Research UKMedical Research Council MC_U105663141Medical Research Council MC_UP_1002/1Medical Research Council MC_UU_00015/2Medical Research Council MC_UU_00015/7Medical Research Council U.1056.00.023(63141)
6 · The paper itself

Abstract

Prostate cancer is one of the leading causes of cancer-related death in men. The identification of new therapeutics to selectively target prostate cancer cells is therefore vital. Recently, the rotenoids rotenone (

Indexed as

AnimalsAntineoplastic AgentsBlood-Brain BarrierCattleCell DivisionCell Line, TumorCell ProliferationCell SurvivalDrug Screening Assays, AntitumorElectron Transport Complex IHumansMaleMitochondrial MembranesMolecular StructureProstatic NeoplasmsRotenoneAntineoplastic AgentsElectron Transport Complex IRotenoneUncoupling Agents

Identifiers

PMID32459967
PMCPMC7611836
OpenAlexW3029809624

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.